Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 589.80m |
Free float | 584.39m |
P/E (TTM) | 29.79 |
Market cap | 41.60bn USD |
EPS (TTM) | 2.37 USD |
Data delayed at least 20 minutes, as of Feb 05 2021.
More ▼
Press releases
- Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
- Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
- TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
- Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
- Edwards Lifesciences Reports Third Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
More ▼